New Leadership Page - etira

Home
Our Company
Our Science
Clinical Trial
Our Pipeline
Our Team
News
Contact
Menu Menu

LinkedIn

Home
Our Company
Our Science
Clinical Trial
Our Pipeline
Our Team
News
Contact

Russell Hayward
Chief Executive Officer

Ganesh V. Raj MD PhD
Founder, Chief Medical Officer & Chief Scientific Officer

Annalisa Jenkins MBBS, MRCP
Board Member

Justin Stebbing MD PhD
Board Member
Editor-in-Chief Oncogene, Professor of Biomedical Sciences, ARU Cambridge.

Russell Hayward
Chief Executive Officer

Ganesh V. Raj MD PhD
Founder, Chief Medical Officer & Chief Scientific Officer

Annalisa Jenkins MBBS, MRCP
Board Member

Justin Stebbing MD PhD
Board Member
Editor-in-Chief Oncogene, Professor of Biomedical Sciences, ARU Cambridge.

Where to find us

Dallas Office:
3033 Irving Blvd,
Dallas. TX. 75247

Mailing Address:
3060 Pegasus Park Dr.
Dallas. TX. 75247

Inclusion criteria:

Patients must be at least 18 years of age at the time of signing the informed consent.
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.
Patients must have histologically or cytologically confirmed solid tumor, primarily including but not limited to breast, ovarian, pancreatic, endometrial, and hepatocellular carcinoma, that is advanced unresectable and/or metastatic disease for whom standard therapies do not exist or are no longer effective
Patients must have measurable disease as per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.
Adequate baseline organ function and hematologic function
Life expectancy >3 months

Exclusion criteria

Systemic anti-cancer therapy within 4 weeks of first dose of study drug
Major surgery (as defined by the Investigator) within 4 weeks of first dose of study drug.
Uncontrolled intercurrent illnesses
Known history of LIPA deficiency, such as Wolman disease or Cholesterol ester storage disease.